Disc Medicine, Inc.
IRON
$77.44
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 6.25% | -4.91% | 2.87% | -12.80% | -62.09% |
| Total Depreciation and Amortization | 1.12% | 0.00% | 2.30% | 2.35% | 325.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 23.31% | 28.04% | 7.91% | 16.45% | 66.93% |
| Change in Net Operating Assets | 114.27% | -219.37% | 32.64% | 2,136.40% | 102.46% |
| Cash from Operations | 28.98% | -43.73% | 9.41% | 0.25% | -15.81% |
| Capital Expenditure | -- | -- | 23.08% | 27.78% | 95.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -62.90% | 126.16% | -549.67% | -4.18% | 119.03% |
| Cash from Investing | -62.90% | 126.16% | -549.94% | -4.16% | 118.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 38.83% | -99.20% | 1,729.36% | 1,199.10% | -99.62% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Financing | 1,805.42% | -99.22% | 1,769.83% | 1,199.10% | -99.63% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 537.41% | 95.49% | -471.55% | 185.80% | 106.68% |